Real-time enrollment status for this persistent corneal epithelial defect clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 8:02 PM UTC
| NCT Number | NCT07519902 |
| Recruiting Status | Recruiting |
| Condition | Persistent Corneal Epithelial Defect |
| Phase | PHASE3 |
| Target Enrollment | 150 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Dompé Farmaceutici S.p.A |
| Last Updated on CT.gov | July 16, 2026 (Jul 16, 2026) |
As of August 28, 2026: Clinical trial NCT07519902 is currently recruiting participants. This phase3 study for persistent corneal epithelial defect is actively seeking new participants at 18 locations across the United States. The study is sponsored by Dompé Farmaceutici S.p.A. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07519902 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07519902 was last updated Jul 16, 2026 (July 16, 2026). HelloStudys verifies this status automatically.